{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T12:05:48Z","timestamp":1785499548158,"version":"3.56.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,9,7]],"date-time":"2015-09-07T00:00:00Z","timestamp":1441584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2015,9,7]],"date-time":"2015-09-07T00:00:00Z","timestamp":1441584000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1038\/cmi.2015.85","type":"journal-article","created":{"date-parts":[[2015,9,7]],"date-time":"2015-09-07T08:40:33Z","timestamp":1441615233000},"page":"285-292","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Potential role of the IL-33\/ST2 axis in celiac disease"],"prefix":"10.1038","volume":"14","author":[{"given":"MA","family":"L\u00f3pez-Casado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Lorite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Palomeque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MI","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,7]]},"reference":[{"key":"BFcmi201585_CR1","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/nri885","volume":"2","author":"LM Sollid","year":"2000","unstructured":"Sollid LM . Celiac disease: dissecting a complex inflammatory disorder. Nat Rev Immunol 2000; 2: 647\u2013655.","journal-title":"Nat Rev Immunol"},{"key":"BFcmi201585_CR2","doi-asserted-by":"publisher","first-page":"289","DOI":"10.7326\/0003-4819-142-4-200502150-00011","volume":"142","author":"A Alaedini","year":"2005","unstructured":"Alaedini A, Green PH . Narrative review: celiac disease: understanding a complex autoimmune disorder. Ann Intern Med 2005; 142: 289\u2013298.","journal-title":"Ann Intern Med"},{"key":"BFcmi201585_CR3","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1093\/intimm\/dxl008","volume":"18","author":"MI Torres","year":"2006","unstructured":"Torres MI, L\u00f3pez-Casado MA, Luque J, Pe\u00f1a J, R\u00edos A . New advances in celiac disease: serum and intestinal expression of HLA-G. Int Immunol 2006; 18: 713\u2013718.","journal-title":"Int Immunol"},{"key":"BFcmi201585_CR4","doi-asserted-by":"publisher","first-page":"S68","DOI":"10.1053\/j.gastro.2005.02.015","volume":"128","author":"A Fasano","year":"2005","unstructured":"Fasano A . Clinical presentation of celiac disease in the pediatric population. Gastroenterology 2005; 128: S68\u2013S73.","journal-title":"Gastroenterology"},{"key":"BFcmi201585_CR5","doi-asserted-by":"publisher","first-page":"4175","DOI":"10.1073\/pnas.0306885101","volume":"101","author":"CY Kim","year":"2004","unstructured":"Kim CY, Quarsten H, Bergseng E, Khosla C, Sollid LM . Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease. Proc Natl Acad Sci USA 2004; 101: 4175\u20134179.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcmi201585_CR6","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.3748\/wjg.v13.i8.1156","volume":"13","author":"MI Torres","year":"2007","unstructured":"Torres MI, L\u00f3pez Casado MA, R\u00edos A . New aspects in celiac disease. World J Gastroenterol 2007; 13: 1156\u20131161.","journal-title":"World J Gastroenterol"},{"key":"BFcmi201585_CR7","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1084\/jem.169.1.345","volume":"169","author":"LM Sollid","year":"1989","unstructured":"Sollid LM, Markussen G, Ek J, Gjerde H, Vartdal F, Thorsby E . Evidence for a primary association of celiac disease to a particular HLA-DQ alpha\/beta heterodimer. J Exp Med 1989; 169: 345\u2013350.","journal-title":"J Exp Med"},{"key":"BFcmi201585_CR8","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/73200","volume":"6","author":"RP Anderson","year":"2000","unstructured":"Anderson RP, Degano P, Godkin AJ . In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope. Nat Med 2000; 6: 337\u2013342.","journal-title":"Nat Med"},{"key":"BFcmi201585_CR9","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1126\/science.1074129","volume":"297","author":"L Shan","year":"2002","unstructured":"Shan L, Molberg \u00d8, Parrot I, Hausch F, Filiz F, Gray GM et al. Structural basis for gluten intolerance in celiac sprue. Science 2002; 297: 2275\u20132279.","journal-title":"Science"},{"key":"BFcmi201585_CR10","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1002\/mnfr.201200358","volume":"56","author":"I Comino","year":"2012","unstructured":"Comino I, Real A, Gil-Humanes J, Pist\u00f3n F, de Lorenzo L, Moreno Mde L et al. Significant differences in celiac immunotoxicity of barley varieties. Mol Nutr Food Res 2012; 56: 1697\u20131707.","journal-title":"Mol Nutr Food Res"},{"key":"BFcmi201585_CR11","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1136\/gut.2010.225268","volume":"60","author":"I Comino","year":"2011","unstructured":"Comino I, Real A, de Lorenzo L, Cornell H, L\u00f3pez-Casado M\u00c1, Barro F et al. Diversity in oat potential immunogenicity: basis for the selection of oat varieties with no toxicity in celiac disease. Gut 2011; 60: 915\u2013922.","journal-title":"Gut"},{"key":"BFcmi201585_CR12","doi-asserted-by":"publisher","first-page":"e48365","DOI":"10.1371\/journal.pone.0048365","volume":"7","author":"A Real","year":"2012","unstructured":"Real A, Comino I, de Lorenzo L, Merch\u00e1n F, Gil-Humanes J, Gim\u00e9nez MJ et al. Molecular and immunological characterization of gluten proteins isolated from oat cultivars that differ in toxicity for celiac disease. PLoS One 2012; 7: e48365. doi: 10.1371\/journal.pone.0048365.","journal-title":"PLoS One"},{"key":"BFcmi201585_CR13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1600-065X.2008.00624.x","volume":"223","author":"WP Arend","year":"2008","unstructured":"Arend WP, Palmer G, Gabay C . IL-1, IL-18, and IL-33 families of cytokines. Immunol Rev 2008; 223: 20\u201338.","journal-title":"Immunol Rev"},{"key":"BFcmi201585_CR14","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nri2691","volume":"10","author":"JE Sims","year":"2010","unstructured":"Sims JE, Smith DE . The IL-1 family: regulators of immunity. Nat Rev Immunol 2010; 10: 89\u2013102.","journal-title":"Nat Rev Immunol"},{"key":"BFcmi201585_CR15","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/nri2692","volume":"10","author":"FY Liew","year":"2010","unstructured":"Liew FY, Pitman NI, McInnes IB . Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat Rev Immunol 2010; 10: 103\u2013110.","journal-title":"Nat Rev Immunol"},{"key":"BFcmi201585_CR16","doi-asserted-by":"publisher","first-page":"i43","DOI":"10.1136\/ard.2009.120113","volume":"69","author":"GE Murphy","year":"2010","unstructured":"Murphy GE, Xu D, Liew FY, McInnes IB . Role of interleukin 33 in human immunopathology. Ann Rheum Dis 2010; 69: i43\u2013i47.","journal-title":"Ann Rheum Dis"},{"key":"BFcmi201585_CR17","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1073\/pnas.0606854104","volume":"104","author":"V Carriere","year":"2007","unstructured":"Carriere V, Roussel L, Ortega N, Lacorre DA, Americh L, Aguilar L et al. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc Natl Acad Sci USA 2007; 104: 282\u2013287.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcmi201585_CR18","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","volume":"23","author":"J Schmitz","year":"2005","unstructured":"Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005; 23: 479\u2013490.","journal-title":"Immunity"},{"key":"BFcmi201585_CR19","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.it.2009.03.003","volume":"30","author":"G Haraldsen","year":"2009","unstructured":"Haraldsen G, Balogh J, Pollheimer J, Sponheim J, Kchler AM . Interleukin-33 \u2013 cytokine of dual function or novel alarmin? Trends Immunol 2009; 30: 227\u2013233.","journal-title":"Trends Immunol"},{"key":"BFcmi201585_CR20","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1006\/geno.2000.6269","volume":"67","author":"H Li","year":"2000","unstructured":"Li H, Tago K, Io K, Kuroiwa K, Arai T, Iwahana H et al. The cloning and nucleotide sequence of human ST2L cDNA. Genomics 2000; 67: 284\u2013290.","journal-title":"Genomics"},{"key":"BFcmi201585_CR21","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.cyto.2008.03.008","volume":"42","author":"G Palmer","year":"2008","unstructured":"Palmer G, Lipsky BP, Smithgall MD, Meininger D, Siu S, Talabot-Ayer D et al. The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33. Cytokine 2008; 42: 358\u2013364.","journal-title":"Cytokine"},{"key":"BFcmi201585_CR22","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1164\/ajrccm.164.2.2008120","volume":"164","author":"K Oshikawa","year":"2001","unstructured":"Oshikawa K, Kuroiwa K, Tago K, Iwahana H, Yanagisawa K, Ohno S et al. Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation. Am J Respir Crit Care Med 2001; 164: 277\u2013281.","journal-title":"Am J Respir Crit Care Med"},{"key":"BFcmi201585_CR23","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1006\/bbrc.2001.5090","volume":"284","author":"K Kuroiwa","year":"2001","unstructured":"Kuroiwa K, Arai T, Okazaki H, Minota S, Tominaga S . Identification of human ST2 protein in the sera of patients with autoimmune diseases. Biochem Biophys Res Comm 2001; 284: 1104\u20131108.","journal-title":"Biochem Biophys Res Comm"},{"key":"BFcmi201585_CR24","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jbspin.2011.02.011","volume":"79","author":"D Talabot-Ayer","year":"2012","unstructured":"Talabot-Ayer D, McKee T, Gindre P, Bas S, Baeten DL, Gabay C et al. Distinct serum and synovial fluid interleukin (IL)-33 levels in rheumatoid arthritis, psoriatic arthritis and osteoarthritis. Joint Bone Spine 2012; 79: 32\u201337.","journal-title":"Joint Bone Spine"},{"key":"BFcmi201585_CR25","doi-asserted-by":"publisher","first-page":"26369","DOI":"10.1074\/jbc.M704916200","volume":"282","author":"H Hayakawa","year":"2007","unstructured":"Hayakawa H, Hayakawa M, Kume A, Tominaga S . Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation. J Biol Chem 2007; 282: 26369\u201326380.","journal-title":"J Biol Chem"},{"key":"BFcmi201585_CR26","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/0016-5085(92)91819-P","volume":"102","author":"MN Marsh","year":"1992","unstructured":"Marsh MN . Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (\u2018celiac sprue\u2019). Gastroenterology 1992; 102: 330\u2013354.","journal-title":"Gastroenterology"},{"key":"BFcmi201585_CR27","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1097\/00042737-199910000-00019","volume":"11","author":"G Oberhuber","year":"1999","unstructured":"Oberhuber G, Granditsch G, Vogelsang H . The histopathology of celiac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol 1999; 11: 1185\u20131194.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"BFcmi201585_CR28","first-page":"109","volume":"16","author":"CJ Beltr\u00e1n","year":"2010","unstructured":"Beltr\u00e1n CJ, N\u00fa\u00f1ez LE, D\u00edaz-Jim\u00e9nez D, Farfan N, Candia E, Heine C et al. Characterization of the novel ST2\/IL-33 system in patients with inflammatory bowel disease. Inflamm Bowel Dis 2010; 16: 109\u2013117.","journal-title":"Inflamm Bowel Dis"},{"key":"BFcmi201585_CR29","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1002\/eji.200737547","volume":"10","author":"M Komai-Koma","year":"2007","unstructured":"Komai-Koma M, Xu D, Li Y, McKenzie AN . IL-33 is a chemoattractant for human Th2 cells. Eur J Immunol 2007; 10: 2779\u20132786.","journal-title":"Eur J Immunol"},{"key":"BFcmi201585_CR30","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","volume":"23","author":"J Schmitz","year":"2005","unstructured":"Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005; 23: 479\u2013490.","journal-title":"Immunity"},{"key":"BFcmi201585_CR31","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1093\/intimm\/dxn060","volume":"20","author":"MD Smithgall","year":"2008","unstructured":"Smithgall MD, Comeau MR, Yoon BR, Kaufman D, Armitage R, Smith DE . IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK Cells. Int Immunol 2008; 20: 1019\u20131030.","journal-title":"Int Immunol"},{"key":"BFcmi201585_CR32","doi-asserted-by":"crossref","unstructured":"Pastorelli L, De Salvo C, Vecchi M, Pizarro TT . The role of IL-33 in gut mucosal inflammation. Mediators Inflamm 2013; ID 608187: 11 p.","DOI":"10.1155\/2013\/608187"},{"key":"BFcmi201585_CR33","doi-asserted-by":"publisher","first-page":"7890","DOI":"10.4049\/jimmunol.0802449","volume":"183","author":"T Ohno","year":"2009","unstructured":"Ohno T, Oboki K, Kajiwara N, Morii E, Aozasa K, Flavell RA et al. Caspase-1, caspase-8, and calpain are dispensable for IL-33 release by macrophages. J Immunol 2009; 183: 7890\u20137897.","journal-title":"J Immunol"},{"key":"BFcmi201585_CR34","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.cyto.2007.09.013","volume":"40","author":"D Moulin","year":"2007","unstructured":"Moulin D, Donz\u00e9 O, Talabot-Ayer D, M\u00e9zin F, Palmer G, Gabay C . Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells. Cytokine 2007; 40: 216\u2013225.","journal-title":"Cytokine"},{"key":"BFcmi201585_CR35","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1002\/eji.201141629","volume":"41","author":"Q Yang","year":"2011","unstructured":"Yang Q, Li G, Zhu Y, Liu L, Chen E, Turnquist H et al. IL-33 synergizes with TCR and IL-12 signaling to promote the effector function of CD8+ T cells. Eur J Immunol 2011; 41: 3351\u20133360.","journal-title":"Eur J Immunol"},{"key":"BFcmi201585_CR36","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1002\/eji.200838575","volume":"39","author":"E Bourgeois","year":"2009","unstructured":"Bourgeois E, Van LP, Samson M, Diem S, Barra A, Roga S et al. The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-gamma production. Eur J Immunol 2009; 39: 1046\u20131055.","journal-title":"Eur J Immunol"},{"key":"BFcmi201585_CR37","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1002\/1521-4141(2002010)32:10<2979::AID-IMMU2979>3.0.CO;2-5","volume":"32","author":"S Lecart","year":"2002","unstructured":"Lecart S, Lecointe N, Subramaniam A, Alkan S, Ni D, Chen R et al. Activated, but not resting human Th2 cells, in contrast to Th1 and T regulatory cells, produce soluble ST2 and express low levels of ST2L at the cell surface. Eur J Immunol 2002; 32: 2979\u20132987.","journal-title":"Eur J Immunol"},{"key":"BFcmi201585_CR38","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.cyto.2011.12.010","volume":"58","author":"Z Xiangyang","year":"2012","unstructured":"Xiangyang Z, Lutian Y, Lin Z, Liping X, Hui S, Jing L . Increased levels of interleukin-33 associated with bone erosion and interstitial lung diseases in patients with rheumatoid arthritis. Cytokine 2012; 58: 6\u20139.","journal-title":"Cytokine"},{"key":"BFcmi201585_CR39","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1093\/rheumatology\/kep402","volume":"49","author":"MY Mok","year":"2010","unstructured":"Mok MY, Huang FP, Ip WK, Lo Y, Wong FY, Chan EY et al. Serum levels of IL-33 and soluble ST2 and their association with disease activity in systemic lupus erythematosus. Rheumatology 2010; 49: 520\u2013527.","journal-title":"Rheumatology"}],"container-title":["Cellular &amp; Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cmi201585.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cmi201585","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cmi201585.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T11:13:29Z","timestamp":1672744409000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cmi201585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,7]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["BFcmi201585"],"URL":"https:\/\/doi.org\/10.1038\/cmi.2015.85","relation":{},"ISSN":["1672-7681","2042-0226"],"issn-type":[{"value":"1672-7681","type":"print"},{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,7]]},"assertion":[{"value":"20 April 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}